Tapdi Oksijen AS

IS:TNZTP Turkey Medical Care Facilities
Market Cap
$261.24 Million
TL9.26 Billion TRY
Market Cap Rank
#20618 Global
#229 in Turkey
Share Price
TL23.16
Change (1 day)
+0.87%
52-Week Range
TL20.26 - TL60.40
All Time High
TL75.75
About

Tapdi Oksijen Özel Saglik ve Egitim Hizmetleri Sanayi Ticaret A.S. provides various health services in Turkey. It operates medical centers and hospitals; disabled and palliative care centers; and beauty centers. The company offers various services, such as anesthesia and reanimation; biochemistry; brain and nerve surgery; cardiology, cardiology intensive care, and cardiovascular surgery; cosmetic… Read more

Tapdi Oksijen AS (TNZTP) - Net Assets

Latest net assets as of September 2024: TL5.14 Billion TRY

Based on the latest financial reports, Tapdi Oksijen AS (TNZTP) has net assets worth TL5.14 Billion TRY as of September 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (TL6.72 Billion) and total liabilities (TL1.58 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets TL5.14 Billion
% of Total Assets 76.48%
Annual Growth Rate 132.7%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 68.54

Tapdi Oksijen AS - Net Assets Trend (2021–2023)

This chart illustrates how Tapdi Oksijen AS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Tapdi Oksijen AS (2021–2023)

The table below shows the annual net assets of Tapdi Oksijen AS from 2021 to 2023.

Year Net Assets Change
2023-12-31 TL3.11 Billion +73.92%
2022-12-31 TL1.79 Billion +210.99%
2021-12-31 TL574.44 Million --

Equity Component Analysis

This analysis shows how different components contribute to Tapdi Oksijen AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1306.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Retained Earnings TL2.02 Billion 65.04%
Other Components TL1.09 Billion 34.96%
Total Equity TL3.11 Billion 100.00%

Tapdi Oksijen AS Competitors by Market Cap

The table below lists competitors of Tapdi Oksijen AS ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Tapdi Oksijen AS's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 1,786,467,282 to 3,106,191,272, a change of 1,319,723,990 (73.9%).
  • Net income of 822,718,070 contributed positively to equity growth.
  • Dividend payments of 36,234,931 reduced retained earnings.
  • Share repurchases of 47,100,541 reduced equity.
  • New share issuances of 287,849,218 increased equity.
  • Other factors increased equity by 292,492,174.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income TL822.72 Million +26.49%
Dividends Paid TL36.23 Million -1.17%
Share Repurchases TL47.10 Million -1.52%
Share Issuances TL287.85 Million +9.27%
Other Changes TL292.49 Million +9.42%
Total Change TL- 73.87%

Book Value vs Market Value Analysis

This analysis compares Tapdi Oksijen AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.60x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 4.57x to 0.60x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 TL5.07 TL23.16 x
2022-12-31 TL15.76 TL23.16 x
2023-12-31 TL38.40 TL23.16 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Tapdi Oksijen AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 26.49%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 62.65%
  • • Asset Turnover: 0.30x
  • • Equity Multiplier: 1.43x
  • Recent ROE (26.49%) is above the historical average (17.62%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 11.46% 21.27% 0.43x 1.27x TL8.40 Million
2022 14.90% 24.76% 0.48x 1.25x TL87.49 Million
2023 26.49% 62.65% 0.30x 1.43x TL512.10 Million

Industry Comparison

This section compares Tapdi Oksijen AS's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $178,298,086
  • Average return on equity (ROE) among peers: 15.88%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Tapdi Oksijen AS (TNZTP) TL5.14 Billion 11.46% 0.31x $56.66 Million
Nasmed Ozel Saglik Hizmetleri Ticaret AS (EGEPO) $125.52 Million 26.24% 0.71x $39.73 Million
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS (LKMNH) $60.52 Million 2.80% 1.14x $97.17 Million
MLP Saglik Hizmetleri AS (MPARK) $348.86 Million 18.61% 12.11x $157.36 Million